Latest News
The Yale Department of Internal Medicine recently presented its second Voluntary Faculty Awards, which honored voluntary faculty who are involved in teaching medical students, physician associate students, residents, and fellows across Yale School of Medicine (YSM) and Yale New Haven Health (YNHHS) affiliated hospitals.
- February 18, 2025
Joy Kaufman, PhD, professor of psychiatry, has been appointed Deputy Chair for Career Development in the Yale Department of Psychiatry.
- January 02, 2025Source: The Union Journal
A recent study has revealed that approximately 1 in 4 teenagers in certain middle and high schools across the United States have reported abusing prescription stimulants intended for attention deficit hyperactivity disorder within the past year
- December 05, 2024Source: Newsweek
Fentanyl drives overdose deaths despite harm reduction—expert debate broader implications.
- December 05, 2024Source: MSN
Rather than failing, harm reduction strategies, as articulated by Fiellin and colleagues in the New England Journal of Medicine is generating real benefits to patients and society.
- November 14, 2024
A nationwide survey of U.S. psychiatric hospitals shows that fewer than 50% offer buprenorphine, methadone, and/or naltrexone, lifesaving medications that can treat opioid use disorder.
- October 02, 2024
NIH Awards $1.5 Million Grant to Improve Factual Correctness in Large Language Models in Health Care
Funded by the National Library of Medicine, the project aims to improve the reliability of AI-generated responses in medical applications, ensuring more accurate and trustworthy information to support better health care decisions.
- September 23, 2024
The Yale Conference for Alcohol Research and Education (YCARE) 2024 will take place on Saturday, October 19, 2024. The event is a dynamic day of learning, interaction, and collaboration focused on the theme of alcohol research. This year’s in-person event will feature podium talks, breakout sessions, a panel discussion, poster presentations, and more avenues to learn from and network with colleagues.
- August 12, 2024Source: MedPage Today
For pregnant persons with opioid use disorder (OUD), buprenorphine and naloxone used together were associated with similar or better neonatal and maternal outcomes versus buprenorphine alone, a large nationwide population-based cohort study found. YSPH Professor of Epidemiology (Chronic Diseases) Dr. Gail D'Onofrio comments.
- August 05, 2024
Faculty from the Yale School of Medicine and Yale School of Public Health partnered with Ilia State University in Tbilisi, Georgia to improve HIV prevention and treatment in at-risk populations throughout Georgia, located in Eastern Europe.